These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22214583)

  • 1. [Identification of novel therapeutically effective antibiotics using silkworm infection model].
    Hamamoto H; Urai M; Paudel A; Horie R; Murakami K; Sekimizu K
    Yakugaku Zasshi; 2012; 132(1):79-84. PubMed ID: 22214583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of Novel Antibiotic Lysocin E Identified by Silkworm Infection Model].
    Hamamoto H; Sekimizu K
    Yakugaku Zasshi; 2017; 137(4):389-392. PubMed ID: 28381711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of Antibiotics Using Silkworm Bacteria and Fungi Infection Model].
    Hamamoto H; Sekimizu K
    Yakugaku Zasshi; 2018; 138(7):895-899. PubMed ID: 29962465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of silkworm as a host animal for understanding pathogenicity of Cryptococcus neoformans.
    Ishii M; Matsumoto Y; Sekimizu K
    Drug Discov Ther; 2016 Feb; 10(1):9-13. PubMed ID: 26902902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Silkworm Infection Model to Evaluate Antifungal Drugs for Cryptococcosis].
    Matsumoto Y; Ishii M; Shimizu K; Kawamoto S; Sekimizu K
    Med Mycol J; 2017; 58(4):E131-E137. PubMed ID: 29187715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantages of the Silkworm As an Animal Model for Developing Novel Antimicrobial Agents.
    Panthee S; Paudel A; Hamamoto H; Sekimizu K
    Front Microbiol; 2017; 8():373. PubMed ID: 28326075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silkworm as a model animal to evaluate drug candidate toxicity and metabolism.
    Hamamoto H; Tonoike A; Narushima K; Horie R; Sekimizu K
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Apr; 149(3):334-9. PubMed ID: 18804554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Usefulness of Silkworms as a Model Animal for Evaluating the Effectiveness of Medicine and Food].
    Sekimizu K
    Yakugaku Zasshi; 2017; 137(5):551-562. PubMed ID: 28458287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms.
    Hamamoto H; Kurokawa K; Kaito C; Kamura K; Manitra Razanajatovo I; Kusuhara H; Santa T; Sekimizu K
    Antimicrob Agents Chemother; 2004 Mar; 48(3):774-9. PubMed ID: 14982763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of therapeutic effects and pharmacokinetics of antibacterial chromogenic agents in a silkworm model of Staphylococcus aureus infection.
    Fujiyuki T; Imamura K; Hamamoto H; Sekimizu K
    Drug Discov Ther; 2010 Oct; 4(5):349-54. PubMed ID: 22491238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silkworm fungal infection model for identification of virulence genes in pathogenic fungus and screening of novel antifungal drugs.
    Ishii M; Matsumoto Y; Nakamura I; Sekimizu K
    Drug Discov Ther; 2017 Mar; 11(1):1-5. PubMed ID: 28228617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism and potential application of bacterial infection in the silkworm, Bombyx mori.
    Wang Q; Sun Z; Ma S; Liu X; Xia H; Chen K
    Dev Comp Immunol; 2022 Jun; 131():104381. PubMed ID: 35245606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of anti-infectious reagents in silkworms.
    Hamamoto H; Horie R; Sekimizu K
    Sci Rep; 2019 Jul; 9(1):9451. PubMed ID: 31263251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Mycobacterium activity of microbial peptides in a silkworm infection model with Mycobacterium smegmatis.
    Yagi A; Uchida R; Hamamoto H; Sekimizu K; Kimura KI; Tomoda H
    J Antibiot (Tokyo); 2017 May; 70(5):685-690. PubMed ID: 28446822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Anti-Mycobacterial Compounds in a Silkworm Infection Model with
    Hosoda K; Koyama N; Hamamoto H; Yagi A; Uchida R; Kanamoto A; Tomoda H
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33121091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of anti-diabetic drugs by using silkworm, Bombyx mori.
    Matsumoto Y; Sekimizu K
    Drug Discov Ther; 2016 Feb; 10(1):19-23. PubMed ID: 26961328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current use of silkworm larvae (Bombyx mori) as an animal model in pharmaco-medical research.
    Nwibo DD; Hamamoto H; Matsumoto Y; Kaito C; Sekimizu K
    Drug Discov Ther; 2015 Apr; 9(2):133-5. PubMed ID: 25994065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitating Drug Discovery in Human Disease Models Using Insects.
    Matsumoto Y
    Biol Pharm Bull; 2020; 43(2):216-220. PubMed ID: 32009109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress and perspective of silkworm as a model of human diseases for drug screening].
    Chen M; Song JB; Li ZQ; Tang DM; Tong XL; Dai FY
    Yao Xue Xue Bao; 2016 May; 51(5):690-7. PubMed ID: 29874005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using silkworms to establish alternative animal models for evaluation of drug-induced tissue injury.
    Inagaki Y; Matsumoto Y; Sekimizu K
    Drug Discov Ther; 2016 Feb; 10(1):40-3. PubMed ID: 26971554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.